Pharmacy chronic disease project
October 27, 2011
THE Pharmacy Guild has
announced a 30-month R&D
project to be undertaken by Griffith
University into the role that
community pharmacies can play in
the care of patients with chronic
illnesses.
The research will be funded via
the Fifth Community Pharmacy
Agreement R&D Program, with the
aim of better understanding the
burden of chronic disease leading
to recommendations for the
development of improved models
of care in Australian health.
About 600 health consumers and
carers will take part in the project,
along with 200 health professionals
in the Logan-Beaudesert, Fraser
Island and Mt Isa regions of
Queensland, along with northern
NSW and the greater Perth area in
Western Australia.
“The burden of taking many
medications is often imposed on
people with little coordination and
with little recognition that these
regimens are demanding in time
and effort,” said Griffith team
leader, Associate Professor Amanda
Wheeler.
“Most people with chronic
conditions interact regularly with a
pharmacy but little is known about
how they see the role of the
pharmacy in their care,” she said.
National Pharmacy Guild
president, Kos Sclavos, said that
with the increasing burden of
chronic disease in Australia,
“pharmacists are ideally placed to
provide additional chronic disease
management services.
“This research project will provide
further data on which to base
future community pharmacy
professional services,” he said.
Associate Professor Wheeler is
also the research leader for a
recently announced 5CPA R&D
project into pharmacy involvement
with mental health (PD 19 Oct).
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Oct 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Oct 11
